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The Update is a bi-weekly Web 
newsletter published by the Iowa 
Department of Public Health’s Bureau 
of Family Health.  It is posted the 
second and fourth week of every 
month, and provides useful job 
resource information for departmental 
health care professionals, 
information on training opportunities, 
intradepartmental reports and 
meetings, and additional information 
pertinent to health care professionals.
March 22, 2010
National Public Health Week
“A Healthier America: One Community at a Time”
The Iowa Department of Public Health and its partners join the 
American Public Health Association in celebrating National Public 
Health Week from April 5-11, 2010. The theme of this important 
observance, “A Healthier America: One Community at a Time,” 
provides public health partners in Iowa with a unique opportunity to:
Demonstrate the importance of public health in promoting and   
 protecting the health of community members and the    
 community itself; 
Showcase the efforts of local public health partners to achieve the  
 goal of creating a healthier Iowa and America, one community at a  
 time; and 
Increase engagement in and support for simple solutions   
 that improve personal and community health through schools,   
 workplaces, and other community partnerships. 
“This year’s primary deliverable is a series of one-page success 
stories that feature the good work of our local partners, who are 
working hard to make their community a healthier place to live, learn, 
work and play.”
“An added feature this year is a directory of county public health 
agencies.  In particular, NPHW organizers encourage those involved 
in community health initiatives, schools, and workplace wellness to 
contact their local health department to explore partnerships during 
National Public Health Week.”
What’s happening in your community?
Go to www.idph.state.ia.us/webmap/default.
asp?map=preparedness_contacts and click on the interactive map to 
contact your local public health agency.
Visit to www.idph.state.ia.us/nphw.asp for more information about 
National Public Health Week (NPHW), how you can get involved, 
how you can make NPHW work for you or download the “Healthy 
Communities” magazine (20 MB), produced for the 2007 “Barn 
Raising” Governor’s Conference on Public Health.  You can also 
download graphics for display or printed materials.
What Health 
Reform Means for 
MCH
On March 21, 2010 the U.S. House of Representatives passed 
a health reform package consisting of the Patient Protection and 
Affordable Care Act by a fi nal vote of 219 to 212 and  the Health 
Care and Education Affordability Reconciliation Act of 2010, also by 
a fi nal vote of 220 to 211. On March 23, President Obama signed the 
Patient Protection and Affordable Care Act  into law. 
What’s Next?  - To complete health reform passage, the 
Senate will now take up the Health Care and Education Affordability 
Reconciliation Act of 2010. This means that the funding for the 
Maternal, Infant, and Early Childhood Home Visitation program and 
the Prevention and Public Health Fund among many other provisions 
should soon be reality.  
   
The Association of Maternal & Child Health 
Programs (AMCHP) provides a brief overview 
that highlights some important MCH-related 
in the Senate Health Reform Bil l .   To view 
the AMCHP overview, go to www.amchp.org/
Advocacy/health-reform/Pages/default .aspx.
Training: Child Safety 
in the Outdoor Play and 
Learning Environment
Collegues:  On April 22, 
2010, from 2-4 p.m., Healthy 
Child Care Iowa will host 
an ICN training session 
with Heather Olsen, Ed.D., 
from the National Program 
for Playground Safety.  The 
target audience is program 
administrators, teachers, 
nurses and consultants.  For 
more information and to 
register, go to the Iowa Public 
Television Web site at 
www.iptv.org/iowa_database/
event-detail.cfm?ID=10443.
To register for this session, 
click on the link provided.  
Read through the description 
of the event, then click on 
“register here” and follow 
the step by step instructions.  
You are welcome to request 
any room in Iowa.  Watch 
you inbox for a confirmation/
denial e-mail.  If the site you 
selected is denied, IPTV 
is happy to help you find 
a room that will work.  You 
may contact IPTV at 1-800-
532-1290 or (515) 242-4181; 
(515) 242-4187 or by e-mail at 
abby@iptv.org.
Please share this 
announcement with your 
colleagues.
NACCRRA Releases Latest Report
On March 11, 2010, the National Association of Child Care 
Resource & Referral Agencies released its latest report - 
Leaving Children to Chance: NACCRRA’s Ranking of State 
Standards and Oversight of Small Family Child Care Homes, 
2010 Update.  This report, which took an in-depth look at small 
family child care home regulations two years after the release 
of the fi rst report, revealed that most states are still failing to 
protect the health, safety and well-being of children in small 
family child care homes.
To view the report, go to www.naccrra.org/publications/naccrra-
publications/leaving-children-to-chance.
Best Practices - VNA of 
Dubuque PSA
The following is a public service announcement developed by the 
staff at VNA of Dubuque that they plan to air on local radio stations 
several weeks before Mother’s Day (May 9).  Please consider doing 
something similar in your service area:
Mother ’s Day is May 9
Each year in the U.S.,  more than 500,000 are 
born prematurely.   The Nat ional  Heal thy Mothers, 
Heal thy Babies Coal i t ion is launching “ text4baby”, 
a f ree mobi le informat ion service that provides 
pregnant women and new moms with informat ion to 
help them care for  their  heal th and give their  babies 
the best start  in l i fe.   I f  you are pregnant or a new 
mom, “ text4baby” can help keep you and your baby 
heal thy.   Sign up for the service by text ing “BABY” 
to 511411 to receive f ree text  messages each week, 
t imed to your due date or baby’s date of  b i r th.
Act ions you can take to have a heal thy baby 
include:
 Take a multi-vitamin containing at least 400   
 mcg of folic acid daily.  Taken before pregnancy,  
 folic acid can reduce birth defects of the brain and  
 spine.
 Don’t smoke and avoid second hand smoke.    
 Smoking increases the risk of premature birth.
 Don’t use alcohol or i l legal drugs.  They can cause  
 l i felong health problems for the baby.
Need help f inding a prenatal health care 
provider,  paying for prenatal care or 
obtaining healthy food?  Call  the Clayton 
County Visit ing Nurse Association Maternal 
Health Program and the Women, Infants and 
Children (WIC) program toll-free at 1-800-
836-7867 today.
Regional Child 
Protection Center 
Workshop Series
The Regional Child Protection 
Center at Blank Children’s 
Hospital seeks to improve 
outcomes for child victims 
of abuse by providing free 
educational opportunities for 
members of our professional 
community.  The purpose of the 
Workshop Series is to impact 
the systematic coordination of 
services for children and families 
through increased professional 
knowledge and skills surrounding 
developmentally appropriate, 
child-focus interventions.
To view information about 
upcoming workshops, go to 
pages 8-9 of The UPdate.
Healthy Lifestyles 
Conference
The Healthy Lifestyles 
Conference will be held April 
21, 2010 at the Comfort Suites 
in Burlington, Iowa.  The goal of 
the conference is to inform and 
update participants about current 
health issues regarding obesity; 
increase public awareness of 
overweight issues that affect our 
health and lifestyles; and engage 
particpants in learning about 
effective strategies for providing 
obesity prevention educatation.  
A registration brochure can be 
downloaded from pages 10-15 of 
The UPdate.
Administration/Program Management
Iowa Medicaid Enterprise (IME) Informational Letter #890 - Electronic 
Remittance Advice
As announed in October 2009, beginning with the March 8, 2010 pay cycle, the IME remittance advice 
statement that explains the Medicaid payment will only be available to providers via an electronic 
method.  The IME will no longer supply paper remittance advice statements.  There are two options for 
providers to view their remittance advice statements electronically.
Option 1: View Remittance Advice Images via the Iowa Medicaid Portal Acess (IMPA)
Remittance advice statements are available for free to any enrolled provider through the Medicaid 
Web portal, IMPA.  This secure Web site allows providers to view an exact replica of the former paper 
remittance advices.  Signing up for online access takes approximately ten minutes; providers must do 
the following: 
1. Go to https://secureapp.dhs.state.ia.us/impa click on “register new account” (upper left) and   
 enter the required information and click “create.”  After the account is created:
2. Go to www.tfaforms.com/144326 and complete an access form.  Once that form is completed and  
 the submit button is clicked, the IME will be automatically notifi ed that the account has requested  
 access to the remittance advice.  The form will be reviewed and approved or denied, and an e-mail  
 will be sent as soon as the process is complete to the address listed on the form, within two   
 business days.
Option 2: HIPAA 835 RA Transactions
The HIPAA 835 is a standard transaction that all healthcare payers (such as Medicaid) are required 
to use to communicate details of the payments they make to providers of service.  Iowa Medicaid 
835’s are available through EDISS at www.edissweb.com/med.  To begin receiving 835’s, providers 
must complete enrollment and registration forms.  This can be done online at www.edissweb.com/
med/forms/onboard.html.  EDISS provides a free (downloadable) software program to view and print 
the 835 remittance advice.  This software can also be used to submit electronic claims to the IME.  
Providers can sign up to get an electronic remittance advice statements even if they do not 
submit claims electronically.  For any questions regarding the EDISS process, support is available 
at 1-800-967-7902. 
See Informational Letter #890 on page 16 of The UPdate.  If you have any questions, please contact 
the IME Provider Services Unit at 1-800-338-7909, locally (in Des Moines) at (515) 256-4609 or by 
e-mail at imeproviderservices@dhs.state.ia.us.
Administration/Program Management continued on next page
Administration/Program Management
2010 Childhood Immunization Schedules
The recommended immunization schedules for persons aged 0 through 18 years and the catch-up 
immunization schedule have been approved by the Advisory Committee on Immunization Practices 
(ACIP), the American Academy of Pediatrics (AAP) and the American Academy of Family Physicians 
(AAFP).  See pages 17-19 of The UPdate to view the following three schedules released by the Centers 
for Disease Control and Prevention (CDC).
 Recommended Immunization Schedule for Persons Aged 0 through 6 Years
 Recommended Immunization Schedule for Persons Aged 7 through 18 Years
 Catch-up Immunization Schedule for Persons Aged 4 Months through 18 Years Who Start Late or   
 Who Are More Than 1 Month Behind
Changes for 2010 include:
 The last dose in the inactivated poliovirus vaccine series is now recommended to be administered   
 on or after the 4th birthday and at least 6 months since the previous dose.  In addition, if 4 doses are  
 administered prior to age 4 years, an additional (5th) dose should be administered at age 4 through   
 6 years.
 The hepatitis A footnote has been revised to allow vaccination of children older than 23 months for   
 whom immunity against hepatitis A is desired.
 Revaccination with meningococcal conjugate vaccine is now recommended for children who remain  
 at increased risk of meningococcal disease after 3 years (if the fi rst doese was administered at age 2 
 through 6 years) or after 5 years (if the fi rst dose was administered at age 7 years or older).
 Footnotes for human papillomavirus (HPV) vaccine have been modifi ed to include the availability of   
 an recommendations for bivalent HPV vaccine, and a permissive recommendation for administration  
 of quadrivalent HPV vaccine to males aged 9 through 18 years to reduce the likelihood of acquiring   
 genital warts.
To access a ready-to-print version of the MMWR containing the schedule, go to www.cdc.gov/mmwr/
PDF/wk/mm5851-Immunization.pdf.
Calendar
April 7-8, 2010
35th Annual Conference on Perinatal Medicine
April 13-14, 2010
Iowa Governor’s Conference on Public Health
Scheman Conference Center, Ames
April 29, 2010
Bureau of Family Health Grantee Committee Meeting
9 - 11:30 a.m., ICN
APRIL
Contract Required 
Due Dates
1 - Change CAReS Password
10 - Due: CCNC Encounter 
Data
15 - Due: MH & CH 2010 
Direct Care Chart Audits
15 - Due: FP Chart Audit 
(Internal) Results
15 - Due: GAX & Expenditure 
Report
28 - Export WHIS Records to 
IDPH
30 - Due: FP Supplemental 
Expansion Funds Report
30 - Due: Dental Data Report
30 - Due: hawk-i Grassroots 
Outreach Quarterly Report
 
Bureau of Family Health:  1-800-383-3826 
Teen Line:  1-800-443-8336 
Healthy Families Line:  1-800-369-2229 
FAX:  515-242-6013 
 
NAME PHONE E-MAIL 
Beaman, Janet 281-3052 jbeaman@idph.state.ia.us 
Borst, M. Jane 
(Bureau Chief) 281-4911 jborst@idph.state.ia.us 
Brown, Kim 281-3126 kbrown@idph.state.ia.us 
Clausen, Sally 281-6071 sclausen@idph.state.ia.us 
Connet, Andrew 281-7184 aconnet@idph.state.ia.us 
Cox, Jinifer 281-7085 jcox@idph.state.ia.us 
Dhooge, Lucia 281-7613 ldhooge@idph.state.ia.us 
Ellis, Melissa 242-5980 mellis@idph.state.ia.us 
Goebel, Patrick 281-3826 pgoebel@idph.state.ia.us 
Hageman, Gretchen 281-7585 ghageman@idph.state.ia.us 
Hinton, Carol 281-6924 chinton@idph.state.ia.us 
Hobert Hoch, Heather 281-6880 hhobert@idph.state.ia.us 
Hoffman, Andrea 281-7044 ahoffman@idph.state.ia.us 
Hummel, Brad 281-5401 bhummel@idph.state.ia.us 
Johnson, Marcus 242-6284 mjohnson@idph.state.ia.us 
Jones, Beth 242-5593 bjones@idph.state.ia.us 
McGill, Abby 281-3108 amcgill@idph.state.ia.us 
Miller, Lindsay 281-7368 lmiller@idph.state.ia.us 
Montgomery, Juli 242-6382 jmontgom@idph.state.ia.us 
O’Hollearn, Tammy 242-5639 tohollea@idph.state.ia.us 
Pearson, Analisa 281-7519 apearson@idph.state.ia.us 
Peterson, Janet 242-6388 jpeterso@idph.state.ia.us 
Piper, Kim 281-6466 kpiper@idph.state.ia.us 
Thorud, Jennifer 281-0219 jthorud@idph.state.ia.us 
Trusty, Stephanie 281-4731 strusty@idph.state.ia.us 
Ubiñas, Mary 281-4653 mubinas@idph.state.ia.us 
Wheeler, Denise 281-4907 dwheeler@idph.state.ia.us 
Wolfe, Meghan 281-0219 mwolfe@idph.state.ia.us 
Area code is 515 
Regional Child Protection Center
Workshop Series
Series Overview & Purpose
The Regional Child Protection Center at Blank Children's
Hospital seeks to improve outcomes for child victims of
abuse by providing free educational opportunities for 
members of our professional community.  The purpose of
the Workshop Series is to impact the systemic coordination
of services for children and families through increased 
professional knowledge and skills surrounding 
developmentally appropriate, child-focused interventions. 
Intended Audience
The Workshop Series is intended for professionals
involved in the child protection field including:
Department of Human Service professionals, law
enforcement, attorneys, victim advocates, medical and
mental health providers, family service professionals,
nurses and school-based professionals. 
2010 Workshops
Wednesday, April 14
Impact of Social & Emotional Trauma 
on Early Development
Presented By: Dr. Richard Gaskill, Ed.D.
ChildTrauma Academy Fellow, Clinical Director & Children’s Services
Coordinator, Sumner Mental Health Center,
Wellington, KS
Tuesday, May 25
Best Practices in Child Fatality & 
Severe Child Physical Abuse Investigations
Presented By: Brian Killacky
Supervisor, Cook County States Attorney’s Office,
Capital Lit. Post Conviction DNA Unit Branch 66 Felony Review Unit,
Chicago, IL
Location
The Workshop Series will be
held at the Kelley Conference
Room in the Education &
Research Center on the Iowa
Methodist/Blank Children’s
Campus. Park in the south end
of the parking ramp and take the
southeast elevators to 
Level G. Workshop Series Schedule 
Please choose a morning or afternoon session as the information is repeated. 
Morning Session
8:00 to 8:30 a.m. Registration
8:30 to 10:00 a.m. Presentation
10:00 to 10:15 a.m. Break
10:15 to 11:45 a.m. Presentation
CEU Information
Each workshop session meets the requirements for
approval for:
- Iowa Board of Social Work Examiners: 3 CEU credit hours 
- Iowa Board of Behavioral Science Examiners: 3 CEU credit hours 
- Iowa Board of Psychology Examiners: 3 CEU credit hours
- Iowa Supreme Court Commission - May 25 only: 3 CLE credit hours
- Iowa Board of Certification - Category A Special Populations: 
3 CEU credit hours
- Iowa Board of Nursing Provider #31, Iowa Health – Des Moines:
.36 CEU credit hours
- Iowa Board for the Treatment of Sexual Abusers:
April 14: 3 credit hours of victim related education
May 25: 3 credit hours of treatment related education
- Iowa Department of Public Health, Bureau of EMS, Mercy School of EMS: 
3 CEU credit hours
CEU approval requires the participant’s full-time attendance. CEUs and
CLEs will be offered free of charge and the attendee will be awarded a
certificate of attendance upon completion of the workshop.
Sponsored in partnership by the:
See back for topic/speaker
information and registration.
Afternoon Session
12:30 to 1:00 p.m. Registration
1:00 to 2:30 p.m. Presentation
2:30 to 2:45 p.m. Break
2:45 to 4:15 p.m. Presentation
Regional Child Protection Center
Workshop Series
Wednesday, April 14, 2010
Impact of Social & Emotional Trauma on Early Childhood Development
Presented by: Dr. Richard Gaskill, Ed.D.
ChildTrauma Academy Fellow, Clinical Director & Children's Services Coordinator, 
Sumner Mental Health Center, Wellington, KS
Course Objectives:
- To learn fundamental neurodevelopmental principles impacted by trauma.
- Recognize common symptoms of social and emotional trauma.
- Design intervention programs to remediate developmental trauma.
Tuesday, May 25, 2010
Best Practices in Child Fatality & Severe Child Physical Abuse Investigations
Presented by: Brian Killacky
Supervisor, Cook County States Attorney’s Office, 
Capital Lit. Post Conviction DNA Unit Branch 66 Felony Review Unit, Chicago, IL
Course Objectives:
- To illustrate key investigative issues in the investigation of child fatality and severe physical abuse.
- To expose the investigative practitioner to various forms of CFI (child fatality investigation).
- To illustrate, through investigative examples, the importance of a MDT approach to these complex 
investigations.
Registration - RCPC Workshop Series
Name:___________________________________________  Organization:_____________________________________
Address:_________________________________________  City:___________________ State:________ Zip:_________
Work phone:______________________________________  Email:___________________________________________
Sessions you are registering for:
 Wednesday, April 14  Tuesday, May 25
 Morning  Afternoon  Morning  Afternoon
Register by going online at www.blankchildrens.org or by mailing your registration to: 
Blank Children’s Hospital, Attn: Erin Luft-Wiskus, 1200 Pleasant Street, Des Moines, IA 50309.
CLEs not approved for this session.
April 21, 2010 
 
Comfort Suites, Burlington, Iowa 
Featured Speakers: 
Chef Cyndie Story, PhD, RD 
Zonya Foco, RD, CHFI, CSP 
Mark Towers, BS, MS 
Presented by Southeast Iowa Regional Coalition for Lifestyle Enhancement 
 
 
Christine O’Brien  (319) 753-0193 
Emily Carrick  (319) 372-5225 or 1-800-458-6672 
Patty Steiner  (319) 754-7556 or 1-800-914-1914 
 
Speakers 
Chef Cyndie Story, PhD, RD has a PhD in Food and 
Lodging Management obtained through Iowa State University’s Child 
Nutrition Leadership Academy. She is a Registered Dietitian and culinarian 
working primarily in school foodservice since 1989. Chef Cyndie has 
presented numerous hands on and demonstration style food production and food safety classes throughout the 
U.S. Her specialties include quantity food preparation, recipe development, food safety, work simplification, fresh 
produce fabrication, nutrition, and merchandizing techniques that encourage customers to make healthier choices. 
Chef Cyndie knows the importance of exceptional food quality, presentation, and safety. 
 
Zonya Foco, RD, CHFI, CSP, America's Nutrition Leader, is on a mission 
to win the war on obesity, type-2 diabetes and heart disease. A master of inspiration, 
motivation and visual humor; Zonya reaches millions of people each year with a 
common-sense approach to healthy eating through her TV show, "Zonya's Health 
Bites," best-selling cookbook, Lickety-Split Meals for Health Conscious People on the 
Go!, co-authored health novel, Water with Lemon, and national speaking calendar.  
In January 2008 Zonya joined Bob Greene on a national tour as a guest nutritionist and 
presenter for “Oprah & Bob’s Best Life Challenge,” providing entertaining and educational cooking presentations. 
As a nationally recognized expert on nutrition and wellness, Zonya has partnered with Health Alliance Plan (HAP) 
of Michigan to develop and present HAP’s award-winning Weight Wise program, launched in 2004.  Zonya has 
earned the prestigious Certified Speaking Professional (CSP) designation and her boundless energy inspires 
audiences across North America to stop dieting and start living the healthy life they deserve.  
Zonya received her bachelor's degree from Eastern Michigan University and then worked for eight years as a 
clinical nutritionist for the Michigan Heart and Vascular Institute at St. Joseph Mercy Hospital in Ann Arbor.  
 
Mark Towers, BS, MS is the founder of Speak Out Seminars.  He has been 
educating people in change management workshops throughout the United States, Europe, 
South Africa, Mexico and Canada for eighteen years.  His educational, motivational and 
entertaining programs have provided people with the tools to truly transform their lives.   
Mark has earned two degrees from the University of Iowa.  He received his bachelor's 
degree in Secondary Education in 1972 and his master's degree in Counseling Psychology 
in 1977.  After spending several years in the education field he became a professional 
speaker for audiences such as ABC-TV, Hallmark Card, AT&T, Merrill Lynch, GTE and 
many government agencies. 
Mark Towers' research has been very extensive.  Change is today's only constant.  In order to cope with the 
current environment of "permanent white water," one must be able to continuously reinvent.  Mark applies his 
intelligence, experience, humor and wisdom to nudge you in a new direction. 
Conference Agenda 
Wednesday, April 21, 2010 
 
8:00 – 8:45 a.m.  Registration 
 
8:45 – 8:55 a.m.  Welcome and Introductions 
 
8:55 – 9:05   IDPH Obesity Trends in Iowa 
 
9:05 – 10:30 a.m. Power of One Good Habit  
Zonya Foco, RD, CHFI, CSP 
      
 
10:30 – 10:45 a.m. Beverage Break 
 
10:45 – 12:15 p.m. State of the Plate 
Chef Cyndie, PhD, RD  
      
12:15 – 1:00 p.m. Lunch (Provided) 
 
1:00 – 1:45 p.m.  Breakout Sessions: 
     Too Fickle to be Fit? Zonya Foco 
     Little Changes Can Make Big Differences:  
Mark Towers 
     Feeling Stressed? Celeste Fry 
 
2:00 - 2:45 p.m.  Breakout Sessions 
     Tricks of the Trade! Chef Cyndie 
Ready, Set, Step: Celeste Fry   
Workplace Wellness: Dept of Public Health 
 
 3:00 – 4:15 p.m.  How to Stay Inspired, Energized and Win! 
Mark Towers, BS, MS 
    
4:15 p.m.   Wrap Up, CEUs and Evaluations 
Conference Goals 
 
 Inform and update conference participants about current health issues regarding obesity. 
 
 Increase public awareness of overweight issues that affect our health and lifestyles. 
 
 Engage participants in learning about effective strategies for providing obesity prevention 
education 
 
 
Conference Location 
Comfort Suites 
1780 Stonegate Center Drive 
Highway 61 South, Burlington, Iowa 
 
You may book accommodations at this    
hotel by calling them directly at  
319-753-1300 or through their website at                    
www.comfortsuites.com.  Parking is free. 
 
Funding:  
This conference is funded in part by Great River Medical Center, Lee County 
Health Department and Community Action of Southeast Iowa. 
 
 
Partners/Sponsors 
 
 
 
 
  
 
Conference Registration:   
 
Registration includes lunch, beverage breaks and conference materials. 
 
Registration fee:   $70 if postmarked by April 16, 2010 
After April 16TH, Registration is $90 
Student Registration rate is $25 
 
Cancellation Policy:  Cancellations must be received in writing by April 16, 2010 and are 
subject to a $15 service fee.  After April 16, 2010, substitutions will be accepted but no refunds 
will be given. 
 
Please make your check out to:  SIRCLE Conference 
 
Send your registration fees to: 
 
SIRCLE Conference 
Community Action of Southeast Iowa 
Attention: Christine O’Brien 
2850 Mt. Pleasant Street - Suite 108 
Burlington, Iowa 52601 
FAX: 319-753-0687 
  
CEUs available for the following: 
 
Nurses:   .6 CEUs hours pending approval through Southeastern Community 
College: Provider Number 24. 
   
Dietitians and other disciplines:  A Certificate of 
Attendance will be available for those needing 
CEU documentation. 
 
 
 
 
Please use the form below to register for the Healthy Lifestyles Conference, 
to be held in Burlington, Iowa on April 21, 2010. 
 
Name: ________________________________________________________________________________ 
Title:  __________________________________   RN License Number: ____________________________ 
Organization:___________________________________________________________________________ 
Address: ______________________________________________________________________________ 
City/State/Zip:__________________________________________________________________________ 
Phone: __________________________________________       FAX: ______________________________ 
E-Mail Address: _________________________________________________________________________ 
Please note any Special Needs (Dietary, Disability, Breast Feeding Room, etc.): ______________________ 
______________________________________________________________________________________ 
Conference Fees:  
 Early Bird Registration: Fee $70 – (postmarked by April 16, 2010)  
 Registration: Fee $90 After April 16, 2010 
 Student Registration: Fee $25 
   Check Enclosed (Make check payable to SIRCLE Conference) 
Amount $  ____________________   
Check # ____________________ 
PO #   ____________________ 
Send Check to:  SIRCLE Conference 
Community Action of Southeast Iowa 
Attention: Christine O’Brien 
2850 Mt Pleasant Street - STE 108 
Burlington IA 52601 
FAX: 319-753-0687 
 
Cancellation Policy:  Cancellations must be received in writing by April 16, 2010 and are subject 
to a $15 service fee.  After April 16, 2010, substitutions will be accepted but no refunds will be given. 
IOWA MEDICAID ENTERPRISE - 100 ARMY POST ROAD - DES MOINES, IA  50315 
 
CHESTER J. CULVER, GOVERNOR DEPARTMENT OF HUMAN SERVICES 
PATTY JUDGE, LT. GOVERNOR CHARLES J. KROGMEIER, DIRECTOR 
  
 
INFORMATIONAL LETTER NO. 890 
 
TO: All Iowa Medicaid Providers 
FROM:   Iowa Department of Human Services, Iowa Medicaid Enterprise (IME) 
DATE:   March 15, 2010 
SUBJECT:  Electronic Remittance Advice 
 
As originally announced in October 2009 (Informational Letters 847 and again in 860 and 877), beginning with 
the March 8, 2010 pay cycle, the IME remittance advice statement (RA) that explains the Medicaid payment will 
only be available to providers via an electronic method.  The IME will no longer supply paper RAs.  There are 
two options for providers to view their RAs electronically.  
 
OPTION 1: View RA images via the Iowa Medicaid Portal Access (IMPA) 
 
RAs are available for free to any enrolled provider through the Medicaid web portal, IMPA. This secure website 
allows providers to view an exact replica of the former paper RAs.  Signing up for online access takes 
approximately 10 minutes; providers must do the following: 
 
1. Go to https://secureapp.dhs.state.ia.us/impa/ click on “register new account” (upper left) and enter the 
required information and click “create.”  After the account is created: 
2. Go to http://www.tfaforms.com/144326 and complete an access form. Once that form is completed and 
the submit button is clicked, the IME will be automatically notified that the account has requested access 
to the RA.  The form will be reviewed and approved or denied and an e-mail will be sent as soon as the 
process is complete to the address listed on the form, within 2 business days.  After approval, remittance 
advice will appear as an option when the user logs back into the account they created in step 1.   
 
Public libraries allow access to a computer and the internet free of charge to the general public. 
 
OPTION 2: HIPAA 835 RA Transactions 
 
The HIPAA 835 is a standard transaction that all healthcare payers (such as Medicaid) are required to use to 
communicate details of the payments they make to providers of service.  Iowa Medicaid 835s are available 
through EDISS at http://www.edissweb.com/med/. To begin receiving 835s, providers must complete enrollment 
and registration forms; this can be done online at: http://www.edissweb.com/med/forms/onboard.html.  EDISS 
provides a free (downloadable) software program to view and print the 835 RA. This software can also be used to 
submit electronic claims to the IME. Providers can sign up to get an electronic RA even if they do not submit 
claims electronically. For any questions regarding the EDISS process, support is available at 1-800-967-7902. 
 
Providers are also reminded that effective July 1, 2010 payments will only be transmitted via an electronic format 
and Informational Letters will only be available electronically.  Please refer to the prior Informational Letters 
(noted in the first paragraph); details will continue to be sent on these changes.  
 
Questions?  The IME appreciates your partnership as we work together to serve the needs of Iowa Medicaid 
members.  If you have any questions, please contact the IME Provider Services Unit at 1-800-338-7909, locally 
(in Des Moines) at 515-256-4609 or by e-mail at imeproviderservices@dhs.state.ia.us. 
This schedule includes recommendations in effect as of December 15, 2009. 
Any dose not administered at the recommended age should be administered at a 
subsequent visit, when indicated and feasible. The use of a combination vaccine 
generally is preferred over separate injections of its equivalent component vaccines. 
Considerations should include provider assessment, patient preference, and 
the potential for adverse events. Providers should consult the relevant Advisory 
Committee on Immunization Practices statement for detailed recommendations: 
http://www.cdc.gov/vaccines/pubs/acip-list.htm. Clinically significant adverse 
events that follow immunization should be reported to the Vaccine Adverse Event 
Reporting System (VAERS) at http://www.vaers.hhs.gov or by telephone, 
800-822-7967.
1. Hepatitis B vaccine (HepB). (Minimum age: birth)
At birth:
•	Administer	monovalent	HepB	to	all	newborns	before	hospital	discharge.
•	 If	mother	is	hepatitis	B	surface	antigen	(HBsAg)-positive,	administer	HepB	
and	0.5	mL	of	hepatitis	B	immune	globulin	(HBIG)	within	12	hours	of	birth.
•	 If	mother’s	HBsAg	status	 is	unknown,	administer	HepB	within	12	hours	of	
birth.	Determine	mother’s	HBsAg	status	as	soon	as	possible	and,	if	HBsAg-
positive,	administer	HBIG	(no	later	than	age	1	week).
After the birth dose:
•	The	HepB	series	should	be	completed	with	either	monovalent	HepB	or	a	com-
bination	vaccine	containing	HepB.	The	second	dose	should	be	administered	
at	age	1	or	2	months.	Monovalent	HepB	vaccine	should	be	used	for	doses	
administered	before	age	6	weeks.	The	final	dose	should	be	administered	no	
earlier	than	age	24	weeks.
•	 Infants	 born	 to	HBsAg-positive	mothers	 should	 be	 tested	 for	HBsAg	and	
antibody	to	HBsAg	1	to	2	months	after	completion	of	at	least	3	doses	of	the	
HepB	series,	at	age	9	through	18	months	(generally	at	 the	next	well-child	
visit).
•	Administration	of	4	doses	of	HepB	to	infants	is	permissible	when	a	combina-
tion	vaccine	containing	HepB	is	administered	after	the	birth	dose.	The	fourth	
dose	should	be	administered	no	earlier	than	age	24	weeks.
2. Rotavirus vaccine (RV).	(Minimum	age:	6	weeks)
•	Administer	 the	 first	 dose	at	 age	6	 through	14	weeks	 (maximum	age:	14	
weeks	6	days).	Vaccination	should	not	be	initiated	for	infants	aged	15	weeks	
0 days or older.
•	The	maximum	age	for	the	final	dose	in	the	series	is	8	months	0	days
•	 If	Rotarix	is	administered	at	ages	2	and	4	months,	a	dose	at	6	months	is	not	
indicated.
3. Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP).
(Minimum	age:	6	weeks)
•	The	fourth	dose	may	be	administered	as	early	as	age	12	months,	provided	
at least 6 months have elapsed since the third dose.
•	Administer	the	final	dose	in	the	series	at	age	4	through	6	years.	
4. Haemophilus influenzae type b conjugate vaccine (Hib).
(Minimum	age:	6	weeks)
•	 If	PRP-OMP	(PedvaxHIB	or	Comvax	[HepB-Hib])	is	administered	at	ages	2	
and 4 months, a dose at age 6 months is not indicated.
•	TriHiBit	(DTaP/Hib)	and	Hiberix	(PRP-T)	should	not	be	used	for	doses	at	ages	
2, 4, or 6 months for the primary series but can be used as the final dose in 
children aged 12 months through 4 years. 
5. Pneumococcal vaccine. (Minimum	age:	6	weeks	for	pneumococcal	conjugate	
vaccine	[PCV];	2	years	for	pneumococcal	polysaccharide	vaccine	[PPSV])
•	PCV	is	recommended	for	all	children	aged	younger	than	5	years.	Administer	
1 dose of PCV to all healthy children aged 24 through 59 months who are 
not completely vaccinated for their age.
•	Administer	PPSV	2	or	more	months	after	last	dose	of	PCV	to	children	aged	2	
years or older with certain underlying medical conditions, including a cochlear 
implant. See MMWR	1997;46(No.	RR-8).
6. Inactivated poliovirus vaccine (IPV) (Minimum	age:	6	weeks)
•	The	final	dose	 in	 the	series	should	be	administered	on	or	after	 the	 fourth	
birthday and at least 6 months following the previous dose.
•	 If	4	doses	are	administered	prior	to	age	4	years	a	fifth	dose	should	be	admin-
istered at age 4 through 6 years. See MMWR	2009;58(30):829–30.
7. Influenza vaccine (seasonal). (Minimum age: 6 months for trivalent inacti-
vated	influenza	vaccine	[TIV];	2	years	for	live,	attenuated	influenza	vaccine	
[LAIV])
•	Administer	annually	to	children	aged	6	months	through	18	years.
•	For	healthy	children	aged	2	through	6	years	(i.e.,	those	who	do	not	have	under-
lying medical conditions that predispose them to influenza complications), 
either	LAIV	or	TIV	may	be	used,	except	LAIV	should	not	be	given	to	children	
aged 2 through 4 years who have had wheezing in the past 12 months.
•	Children	receiving	TIV	should	receive	0.25	mL	if	aged	6	through	35	months	
or	0.5	mL	if	aged	3	years	or	older.
•	Administer	2	doses	(separated	by	at	least	4	weeks)	to	children	aged	younger	
than 9 years who are receiving influenza vaccine for the first time or who were 
vaccinated for the first time during the previous influenza season but only 
received 1 dose.
•	For	recommendations	for	use	of	influenza	A	(H1N1)	2009	monovalent	vaccine	
see MMWR	2009;58(No.	RR-10).
8. Measles, mumps, and rubella vaccine (MMR). (Minimum age: 12 months)
•	Administer	the	second	dose	routinely	at	age	4	through	6	years.	However,	the	
second	dose	may	be	administered	before	age	4,	provided	at	least	28	days	
have elapsed since the first dose.
9. Varicella vaccine. (Minimum age: 12 months) 
•	Administer	the	second	dose	routinely	at	age	4	through	6	years.	However,	the	
second	dose	may	be	administered	before	age	4,	provided	at	least	3	months	
have elapsed since the first dose.
•	For	children	aged	12	months	through	12	years	the	minimum	interval	between	
doses	is	3	months.	However,	if	the	second	dose	was	administered	at	least	
28	days	after	the	first	dose,	it	can	be	accepted	as	valid.
10. Hepatitis A vaccine (HepA). (Minimum age: 12 months)
•	Administer	 to	 all	 children	aged	1	 year	 (i.e.,	 aged	12	 through	23	months).	
Administer 2 doses at least 6 months apart.
•	Children	not	fully	vaccinated	by	age	2	years	can	be	vaccinated	at	subsequent	
visits
•	HepA	also	is	recommended	for	older	children	who	live	in	areas	where	vac-
cination	programs	target	older	children,	who	are	at	increased	risk	for	infection,	
or for whom immunity against hepatitis A is desired.
11. Meningococcal vaccine. (Minimum age: 2 years for meningococcal conjugate 
vaccine	[MCV4]	and	for	meningococcal	polysaccharide	vaccine	[MPSV4])
•	Administer	MCV4	to	children	aged	2	through	10	years	with	persistent	comple-
ment component deficiency, anatomic or functional asplenia, and certain other 
conditions	placing	tham	at	high	risk.
•	Administer	MCV4	 to	children	previously	vaccinated	with	MCV4	or	MPSV4	
after	3	years	if	first	dose	administered	at	age	2	through	6	years.	See	MMWR 
2009;	58:1042–3.
Range of  
recommended 
ages for certain 
high-risk	groups
Range of 
recommended 
ages for all 
children	except	
certain	high-risk	
groups
Vaccine ▼ Age ► Birth
1
month
2
months
4
months
6
months
12
months
15
months
18
months
19–23
months
2–3
years
4–6
years
Hepatitis	B1 HepB
Rotavirus2 RV RV RV2
Diphtheria, Tetanus, Pertussis3 DTaP DTaP DTaP
see  
footnote3
Haemophilus influenzae type b4 Hib Hib Hib4
Pneumococcal5 PCV PCV PCV
Inactivated Poliovirus6 IPV IPV
Influenza7
Measles, Mumps, Rubella8 see footnote8
Varicella9 see footnote9
Hepatitis	A10
Meningococcal11
HepBHepB
DTaP DTaP
Hib
IPVIPV
MMR
VaricellaVaricella
MMR
PCV
HepA Series
MCV
Influenza (Yearly)
PPSV
HepA (2 doses)
Recommended Immunization Schedule for Persons Aged 0 Through 6 Years—United States • 2010
For	those	who	fall	behind	or	start	late,	see	the	catch-up	schedule
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-A The	Recommended	Immunization	Schedules	for	Persons	Aged	0	through	18	Years	are	approved	by	the	Advisory	Committee	on	Immunization	Practices	
(http://www.cdc.gov/vaccines/recs/acip), the American Academy of Pediatrics (http://www.aap.org),	and	the	American	Academy	of	Family	Physicians	(http://www.aafp.org). 
Department	of	Health	and	Human	Services	•	Centers	for	Disease	Control	and	Prevention
The Recommended Immunization Schedules for Persons Aged 0 through 18 Years are approved by the Advisory Committee on Immunization Practices 
(http://www.cdc.gov/vaccines/recs/acip), the American Academy of Pediatrics (http://www.aap.org), and the American Academy of Family Physicians (http://www.aafp.org). 
Department of Health and Human Services • Centers for Disease Control and Prevention
This schedule includes recommendations in effect as of December 15, 2009. 
Any dose not administered at the recommended age should be administered at a 
subsequent visit, when indicated and feasible. The use of a combination vaccine 
generally is preferred over separate injections of its equivalent component vaccines. 
Considerations should include provider assessment, patient preference, and 
the potential for adverse events. Providers should consult the relevant Advisory 
Committee on Immunization Practices statement for detailed recommendations: 
http://www.cdc.gov/vaccines/pubs/acip-list.htm. Clinically significant adverse 
events that follow immunization should be reported to the Vaccine Adverse Event 
Reporting System (VAERS) at http://www.vaers.hhs.gov or by telephone, 
800-822-7967.
1. Tetanus and diphtheria toxoids and acellular pertussis vaccine (Tdap). 
(Minimum age: 10 years for Boostrix and 11 years for Adacel)
• Administer at age 11 or 12 years for those who have completed the recom-
mended childhood DTP/DTaP vaccination series and have not received a 
tetanus and diphtheria toxoid (Td) booster dose.
• Persons aged 13 through 18 years who have not received Tdap should receive 
a dose.
• A 5-year interval from the last Td dose is encouraged when Tdap is used as 
a booster dose; however, a shorter interval may be used if pertussis immunity 
is needed.
2. Human papillomavirus vaccine (HPV). (Minimum age: 9 years) 
• Two HPV vaccines are licensed: a quadrivalent vaccine (HPV4) for the pre-
vention of cervical, vaginal and vulvar cancers (in females) and genital warts 
(in females and males), and a bivalent vaccine (HPV2) for the prevention of 
cervical cancers in females.
• HPV vaccines are most effective for both males and females when given 
before exposure to HPV through sexual contact.
• HPV4 or HPV2 is recommended for the prevention of cervical precancers and 
cancers in females.
• HPV4 is recommended for the prevention of cervical, vaginal and vulvar 
precancers and cancers and genital warts in females.
• Administer the first dose to females at age 11 or 12 years. 
• Administer the second dose 1 to 2 months after the first dose and the third 
dose 6 months after the first dose (at least 24 weeks after the first dose). 
• Administer the series to females at age 13 through 18 years if not previously 
vaccinated.
• HPV4 may be administered in a 3-dose series to males aged 9 through 18 
years to reduce their likelihood of acquiring genital warts. 
3. Meningococcal conjugate vaccine (MCV4).
• Administer at age 11 or 12 years, or at age 13 through 18 years if not previ-
ously vaccinated.
• Administer to previously unvaccinated college freshmen living in a 
dormitory. 
• Administer MCV4 to children aged 2 through 10 years with persistent comple-
ment component deficiency, anatomic or functional asplenia, or certain other 
conditions placing them at high risk.
• Administer to children previously vaccinated with MCV4 or MPSV4 who 
remain at increased risk after 3 years (if first dose administered at age 2 
through 6 years) or after 5 years (if first dose administered at age 7 years or 
older). Persons whose only risk factor is living in on-campus housing are not 
recommended to receive an additional dose. See MMWR 2009;58:1042–3.
4. Influenza vaccine (seasonal). 
• Administer annually to children aged 6 months through 18 years.
• For healthy nonpregnant persons aged 7 through 18 years (i.e., those who 
do not have underlying medical conditions that predispose them to influenza 
complications), either LAIV or TIV may be used.
• Administer 2 doses (separated by at least 4 weeks) to children aged younger 
than 9 years who are receiving influenza vaccine for the first time or who were 
vaccinated for the first time during the previous influenza season but only 
received 1 dose.
• For recommendations for use of influenza A (H1N1) 2009 monovalent vaccine. 
See MMWR 2009;58(No. RR-10).
5. Pneumococcal polysaccharide vaccine (PPSV). 
• Administer to children with certain underlying medical conditions, including a 
cochlear implant. A single revaccination should be administered after 5 years 
to children with functional or anatomic asplenia or an immunocompromising 
condition. See MMWR 1997;46(No. RR-8).
6. Hepatitis A vaccine (HepA). 
• Administer 2 doses at least 6 months apart. 
• HepA is recommended for children aged older than 23 months who live in areas 
where vaccination programs target older children, who are at increased risk for 
infection, or for whom immunity against hepatitis A is desired. 
7. Hepatitis B vaccine (HepB).
• Administer the 3-dose series to those not previously vaccinated.
• A 2-dose series (separated by at least 4 months) of adult formulation 
Recombivax HB is licensed for children aged 11 through 15 years.
8. Inactivated poliovirus vaccine (IPV). 
• The final dose in the series should be administered on or after the fourth 
birthday and at least 6 months following the previous dose.
• If both OPV and IPV were administered as part of a series, a total of 4 doses 
should be administered, regardless of the child’s current age.
9. Measles, mumps, and rubella vaccine (MMR). 
• If not previously vaccinated, administer 2 doses or the second dose for those 
who have received only 1 dose, with at least 28 days between doses. 
10. Varicella vaccine. 
• For persons aged 7 through 18 years without evidence of immunity (see 
MMWR 2007;56[No. RR-4]), administer 2 doses if not previously vaccinated 
or the second dose if only 1 dose has been administered.
• For persons aged 7 through 12 years, the minimum interval between doses 
is 3 months. However, if the second dose was administered at least 28 days 
after the first dose, it can be accepted as valid.
• For persons aged 13 years and older, the minimum interval between doses 
is 28 days.
Vaccine ▼ Age ► 7–10 years 11–12 years 13–18 years
Tetanus, Diphtheria, Pertussis1
Human Papillomavirus2 see footnote 2
Meningococcal3
Influenza4
Pneumococcal5
Hepatitis A6
Hepatitis B7
Inactivated Poliovirus8
Measles, Mumps, Rubella9
Varicella10
Tdap
HPV (3 doses)
MCVMCV
Tdap
HPV series
MCV
Influenza (Yearly)
PPSV
HepA Series
Hep B Series
IPV Series
MMR Series
Varicella Series
Range of 
recommended 
ages for 
catch-up
immunization
Range of 
recommended 
ages for all 
children except 
certain high-risk 
groups
Range of  
recommended 
ages for certain 
high-risk groups
Recommended Immunization Schedule for Persons Aged 7 Through 18 Years—United States • 2010
For those who fall behind or start late, see the schedule below and the catch-up schedule
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1. Hepatitis B vaccine (HepB).
•	 Administer	the	3-dose	series	to	those	not	previously	vaccinated.
•	 A	2-dose	series	(separated	by	at	least	4	months)	of	adult	formulation	Recombivax	
HB	is	licensed	for	children	aged	11	through	15	years.
2. Rotavirus vaccine (RV).
•	 The	maximum	age	for	the	first	dose	is	14	weeks	6	days.	Vaccination	should	not	be	
initiated	for	infants	aged	15	weeks	0	days	or	older.
•	 The	maximum	age	for	the	final	dose	in	the	series	is	8	months	0	days.
•	 If	Rotarix	was	administered	 for	 the	first	and	second	doses,	a	 third	dose	 is	not	
indicated.
3. Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP).
•	 The	fifth	dose	is	not	necessary	if	the	fourth	dose	was	administered	at	age	4	years	
or	older.
4. Haemophilus influenzae type b conjugate vaccine (Hib).
•	 Hib	vaccine	is	not	generally	recommended	for	persons	aged	5	years	or	older.	No	
efficacy	data	are	available	on	which	to	base	a	recommendation	concerning	use	of	
Hib	vaccine	for	older	children	and	adults.	However,	studies	suggest	good	immu-
nogenicity	in	persons	who	have	sickle	cell	disease,	leukemia,	or	HIV	infection,	or	
who	have	had	a	splenectomy;	administering	1	dose	of	Hib	vaccine	to	these	persons	
who	have	not	previously	received	Hib	vaccine	is	not	contraindicated.
•	 If	the	first	2	doses	were	PRP-OMP	(PedvaxHIB	or	Comvax),	and	administered	at	
age	11	months	or	younger,	the	third	(and	final)	dose	should	be	administered	at	
age	12	through	15	months	and	at	least	8	weeks	after	the	second	dose.
•	 If	the	first	dose	was	administered	at	age	7	through	11	months,	administer	the	second	
dose	at	least	4	weeks	later	and	a	final	dose	at	age	12	through	15	months.
5. Pneumococcal vaccine.
•	 Administer	1	dose	of	pneumococcal	conjugate	vaccine	(PCV)	to	all	healthy	children	
aged	24	through	59	months	who	have	not	received	at	least	1	dose	of	PCV	on	or	
after	age	12	months.
•	 For	children	aged	24	through	59	months	with	underlying	medical	conditions,	admin-
ister	1	dose	of	PCV	if	3	doses	were	received	previously	or	administer	2	doses	of	
PCV	at	least	8	weeks	apart	if	fewer	than	3	doses	were	received	previously.
•	 Administer	pneumococcal	polysaccharide	vaccine	(PPSV)	to	children	aged	2	years	
or	older	with	certain	underlying	medical	conditions,	including	a	cochlear	implant,	
at	least	8	weeks	after	the	last	dose	of	PCV.	See	MMWR	1997;46(No.	RR-8).
6. Inactivated poliovirus vaccine (IPV).
•	 The	final	dose	in	the	series	should	be	administered	on	or	after	the	fourth	birthday	
and	at	least	6	months	following	the	previous	dose.
•	 A	fourth	dose	is	not	necessary	if	the	third	dose	was	administered	at	age	4	years	
or	older	and	at	least	6	months	following	the	previous	dose.
•	 In	the	first	6	months	of	life,	minimum	age	and	minimum	intervals	are	only	recom-
mended	if	the	person	is	at	risk	for	imminent	exposure	to	circulating	poliovirus	(i.e.,	
travel	to	a	polio-endemic	region	or	during	an	outbreak).
7. Measles, mumps, and rubella vaccine (MMR).
•	 Administer	the	second	dose	routinely	at	age	4	through	6	years.	However,	the	second	
dose	may	be	administered	before	age	4,	provided	at	least	28	days	have	elapsed	
since	the	first	dose.
•	 If	not	previously	vaccinated,	administer	2	doses	with	at	 least	28	days	between	
doses.
8. Varicella vaccine.
•	 Administer	the	second	dose	routinely	at	age	4	through	6	years.	However,	the	second	
dose	may	be	administered	before	age	4,	provided	at	least	3	months	have	elapsed	
since	the	first	dose.
•	 For	persons	aged	12	months	 through	12	years,	 the	minimum	 interval	between	
doses	is	3	months.	However,	if	the	second	dose	was	administered	at	least	28	days	
after	the	first	dose,	it	can	be	accepted	as	valid.
•	 For	persons	aged	13	years	and	older,	the	minimum	interval	between	doses	is	28	
days.
9. Hepatitis A vaccine (HepA).
•	 HepA	is	recommended	for	children	aged	older	than	23	months	who	live	in	areas	
where	vaccination	programs	target	older	children,	who	are	at	 increased	risk	for	
infection,	or	for	whom	immunity	against	hepatitis	A	is	desired.
10. Tetanus and diphtheria toxoids vaccine (Td) and tetanus 
and diphtheria toxoids and acellular pertussis vaccine (Tdap).
•	 Doses	of	DTaP	are	counted	as	part	of	the	Td/Tdap	series
•	 Tdap	should	be	substituted	for	a	single	dose	of	Td	in	the	catch-up	series	or	as	a	
booster	for	children	aged	10	through	18	years;	use	Td	for	other	doses.
11. Human papillomavirus vaccine (HPV).
•	 Administer	 the	 series	 to	 females	 at	 age	13	 through	18	 years	 if	 not	 previously	
vaccinated.
•	 Use	recommended	routine	dosing	intervals	for	series	catch-up	(i.e.,	the	second	and	
third	doses	should	be	administered	at	1	to	2	and	6	months	after	the	first	dose).	The	
minimum	interval	between	the	first	and	second	doses	is	4	weeks.	The	minimum	
interval	between	the	second	and	third	doses	is	12	weeks,	and	the	third	dose	should	
be	administered	at	least	24	weeks	after	the	first	dose.
Information	about	reporting	reactions	after	immunization	is	available	online	at	http://www.vaers.hhs.gov	or	by	telephone,	800-822-7967.	Suspected	cases	of	vaccine-preventable	diseases	should	be	reported	to	the	state	
or	local	health	department.	Additional	information,	including	precautions	and	contraindications	for	immunization,	is	available	from	the	National	Center	for	Immunization	and	Respiratory	Diseases	at	http://www.cdc.gov/
vaccines	or	telephone,	800-CDC-INFO	(800-232-4636).
Department	of	Health	and	Human	Services	•	Centers	for	Disease	Control	and	Prevention
PERSONS AGED 4 MONTHS THROUGH 6 YEARS
Vaccine Minimum Age for Dose 1
Minimum Interval Between Doses
Dose 1 to Dose 2 Dose 2 to Dose 3 Dose 3 to Dose 4 Dose 4 to Dose 5
Hepatitis	B1 Birth 4 weeks 8 weeks(and	at	least	16	weeks	after	first	dose)
Rotavirus2 6	wks 4 weeks 4 weeks2
Diphtheria,	Tetanus,	Pertussis3 6	wks 4 weeks 4 weeks 6 months 6 months3
Haemophilus influenzae type	b4 6	wks
4 weeks
if	first	dose	administered	at	younger	than	age	12	months
8 weeks (as final dose)
if	first	dose	administered	at	age	12–14	months
No further doses needed
if	first	dose	administered	at	age	15	months	or	older
4 weeks4
if	current	age	is	younger	than	12	months
8 weeks (as final dose)4
if	current	age	is	12	months	or	older	and	first	dose	
administered	at	younger	than	age	12	months	and	
second	dose	administered	at	younger	than	15	months
No further doses needed
if	previous	dose	administered	at	age	15	months	or	older
8 weeks (as final dose)
This	dose	only	necessary	
for	children	aged	12	months	
through	59	months	who	
received	3	doses	before	
age	12	months
Pneumococcal5 6	wks
4 weeks
if	first	dose	administered	at	younger	than	age	12	months
8 weeks (as final dose for healthy children)
if	first	dose	administered	at	age	12	months	or	older	
or	current	age	24	through	59	months
No further doses needed
for	healthy	children	if	first	dose	
administered	at	age	24	months	or	older
4 weeks
if	current	age	is	younger	than	12	months
8 weeks
(as final dose for healthy children)
if	current	age	is	12	months	or	older
No further doses needed
for	healthy	children	if	previous	dose	administered	at	age	
24	months	or	older
8 weeks (as final dose)
This	dose	only	necessary	
for	children	aged	12	months	
through	59	months	who	
received	3	doses	before	
age	12	months	or	for	high-
risk	children	who	received	
3	doses	at	any	age
Inactivated	Poliovirus6 6	wks 4 weeks 4 weeks 6 months
Measles,Mumps,	Rubella7 12	mos 4 weeks
Varicella8 12	mos 3 months
Hepatitis	A9 12	mos 6 months
PERSONS AGED 7 THROUGH 18 YEARS
Tetanus,Diphtheria/	
Tetanus,Diphtheria,Pertussis10 7	yrs
10 4 weeks
4 weeks
if	first	dose	administered	at	younger	than	age	12	months
6 months
if	first	dose	administered	at	12	months	or	older
6 months
if	first	dose	administered	at	
younger	than	age	12	months
Human	Papillomavirus11 9	yrs Routine dosing intervals are recommended11
Hepatitis	A9 12	mos 6 months
Hepatitis	B1 Birth 4 weeks 8 weeks(and	at	least	16	weeks	after	first	dose)
Inactivated	Poliovirus6 6	wks 4 weeks 4 weeks 6 months
Measles,Mumps,	Rubella7 12	mos 4 weeks
Varicella8 12	mos
3 months
if	person	is	younger	than	age	13	years
4 weeks
if	person	is	aged	13	years	or	older
The table below provides catch-up schedules and minimum intervals between doses for children whose vaccinations have been delayed. A vaccine 
series does not need to be restarted, regardless of the time that has elapsed between doses. Use the section appropriate for the child’s age.
Catch-up Immunization Schedule for Persons Aged 4 Months Through 18 Years Who Start Late or Who Are More Than 1 Month Behind—United States • 2010
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